SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

SpyGlass Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate Updates

IRVINE, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. NASDAQ:SGP (“SpyGlass Pharma” or “Company”), a late-stage biopharmaceutical company, today reported recent business highlights and financial results for the third quarter ended September 30, 2026.“SpyGlass Pharma continued to e…

SGP

Related stories